Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Article | December 02, 2015

Patent Infringement at the ITC: Implications for Brand-Name Drug Companies

Article | November 18, 2015

Fed. Cir. Limits Safe Harbor for Post-Approval Conduct

Article | October 09, 2015

How Globalization has Shifted the Paradigm of Diversity Inclusion in Intellectual Property Law

Article | September 30, 2015

Safe Harbor Protects Supplier of Active Ingredient for ANDA

Blog | September 02, 2015

Injunction Denied, Sandoz Clear to Launch

Blog | August 27, 2015

BPCIA Dance Partners Request En Banc Rehearing and Amgen Seeks Temporary Injunction

Article | August 12, 2015

Process Patents Are Vital In Biotech — Why Not Extend Them?

Blog | July 27, 2015

Judicial Review Available for Decision that a Patent Qualified for CBM Review; § 101 Review Appropriate in CBM Review

Blog | July 24, 2015

PTAB's Construction Must Be "Reasonable" In Light of All Intrinsic Evidence, PTAB May Require Patentee to Show Amended Claims Are Patentable Over All Prior Art of Record

Blog | July 24, 2015

District Courts Deciding Whether to Modify a Protective Order to Allow U.S. Discovery to Be Used in Foreign Litigation Must Consider Factors Relevant to Section 1782 Proceedings

Article | July 23, 2015

How To Avoid FDA Regulation Of Your Mobile Medical App

Blog | July 22, 2015

Amgen v. Sandoz: Federal Circuit Weighs In on the BPCIA Riddle